Sign Up to like & get
recommendations!
2
Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26918
Abstract: T‐cell prolymphocytic leukemia (T‐PLL) is a rare, post‐thymic T‐cell neoplasm with a diverse clinical course. T‐PLL is typically associated with a poor prognosis; however, a subset of patients have inactive disease on initial presentation. There…
read more here.
Keywords:
prognostic factors;
disease;
clinical course;
course ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2017 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2016.305
Abstract: Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is lacking. We correlated minimal residual disease (MRD) kinetics with immune interventions and…
read more here.
Keywords:
mrd;
mrd kinetics;
evidence;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqae075
Abstract: OBJECTIVES We sought to investigate the morphologic and immunophenotypic characteristics of TCL1 family-negative T-cell prolymphocytic leukemia (T-PLL). METHODS Twenty cases of TCL1 family-negative T-PLL were studied. RESULTS The doubling time of leukemic cells ranged from…
read more here.
Keywords:
immunophenotypic;
tcl1 family;
pll;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqz060
Abstract: OBJECTIVES CD161 (NKRP1) is a lectin-like receptor present on NK cells and rare T-cell subsets. We have observed CD161 expression in some cases of T-cell prolymphocytic leukemia (T-PLL) and found it to be useful in…
read more here.
Keywords:
cd161;
disease;
cell prolymphocytic;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Haematology"
DOI: 10.1111/ejh.12856
Abstract: T‐cell prolymphocytic leukemia (T‐PLL) is a very rare, aggressive T‐cell neoplasm. Peripheral T‐cell lymphoma, not otherwise specified (PTCL‐NOS) is also a highly aggressive lymphoma. These two diseases can often be confused with each other; therefore,…
read more here.
Keywords:
lymphoma;
cell prolymphocytic;
prolymphocytic leukemia;
cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "European Journal of Haematology"
DOI: 10.1111/ejh.13511
Abstract: Infusional alemtuzumab followed by consolidating allogeneic hematopoietic stem cell transplantation in eligible patients is considered a standard of care in T‐cell prolymphocytic leukemia (T‐PLL). Antibody selection against CD52 has been associated with the development of…
read more here.
Keywords:
cd52;
cell prolymphocytic;
mutations piga;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14642
Abstract: A 48-year-old man presented with multiple pruritic dark red papules for 9 months. The lesions started on his hands and subsequently spread to the trunk and limbs within the last 2 months. He also had…
read more here.
Keywords:
pruritic dark;
blood;
cell prolymphocytic;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.14237
Abstract: The typical morphological features of B-cell prolymphocytic leukemia (B-PLL) include a single vesicular nucleolus, condensed chromatin devoid of granules. In this case, we highlight a rare instance of relapsed B-PLL with distinctive granular inclusion bodies.…
read more here.
Keywords:
distinctive granular;
pll;
pll distinctive;
prolymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer research"
DOI: 10.1158/0008-5472.can-21-1908
Abstract: T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-refractory T-cell malignancy with limited therapeutic options and a poor prognosis. Current disease concepts implicate TCL1A oncogene-mediated enhanced T-cell receptor (TCR) signaling and aberrant DNA repair as central perturbed…
read more here.
Keywords:
cell;
ago2;
non canonical;
cell prolymphocytic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/23247096231176223
Abstract: T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm that originates from mature post-thymic T-cells. Cutaneous manifestations are a common presentation in T-PLL but rarely are a presentation in the recurrent setting. Here, we…
read more here.
Keywords:
prolymphocytic leukemia;
pll;
cell prolymphocytic;
diffuse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-03-840611
Abstract: ![Figure][1] A 75-year-old man was referred to us with an outside diagnosis of T-cell prolymphocytic leukemia (T-PLL) posttreatment. He had mild leukocytosis (white blood cell count, 11.5 × 109/L) and multicompartmental lymphadenopathy by positron emission…
read more here.
Keywords:
cell;
negative surface;
cell prolymphocytic;
prolymphocytic leukemia ... See more keywords